When was Pathalys founded?

Pathalys was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Pathalys located?

Pathalys is headquartered in Raleigh, United States.

How many employees does Pathalys have?

As of Sep 30, 2026, the latest employee count at Pathalys is 18.

Is Pathalys a funded company?

Pathalys is a funded company, having raised a total of $105M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jan 19, 2023.

When was the latest funding round of Pathalys?

Pathalys' latest funding was a $***** Series B round on Aug 20, 2024, with participation from 8 investors.

Where does Pathalys rank among its competitors?

Pathalys ranks 12th amongst 198 active competitors, of which 16 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Ceresti, which secured $10M in May, 2026.

Who are the top competitors of Pathalys?

Pathalys' top competitors include Aqtual, Evergreen Nephrology and AdaptX. Among them, Ceresti secured the most recent funding round in May, 2026.

Pathalys - 2026 Company Profile, Team, Funding & Competitors

Pathalys is a series B company based in Raleigh (United States), founded in 2021 by Takeshi Takahashi, Mahesh Krishnan, BT Slingsby, Ashwin Ram and Jay Shepard. It operates as a Provider of CKD biotherapeutics development services. Pathalys has raised $105M in funding from Abingworth and TCG Crossover. The company has 198 active competitors, including 16 funded and 15 that have exited. Its top competitors include companies like Aqtual, Evergreen Nephrology and AdaptX.

Company Details

Website: pathalys.com
Social
Email ID: *****@pathalys.com

Key Metrics

Founded Year

2021

Location

Raleigh, United States

Stage

Series B

Total Funding

$105M in 2 rounds

Latest Funding Round

Series B, Aug 20, 2024, $*****

Investors

Abingworth & 10 more

Ranked

12^th among 198 active competitors

Employee Count

18 as on Sep 30, 2026

Similar Companies

Aqtual & 206 more

View Pathalys' full profile

Pathalys has raised a total funding of $105M over 2 rounds. Its first funding round was on Jan 19, 2023. Its latest funding round was a Series B round on Aug 20, 2024 for $*****. 8 investors participated in its latest round. Pathalys has 11 institutional investors.

Here is the list of recent funding rounds of Pathalys:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 20, 2024	4270680	Series B	1496707	4333972	8170230	2218001
Jan 19, 2023	2884071	Seed	1141516	6843366	Abingworth	The Carlyle Group & 3 more

Access funding benchmarks and valuations. Sign up today!

View details of Pathalys's funding rounds and investors

The founders of Pathalys are Takeshi Takahashi, Mahesh Krishnan, BT Slingsby, Ashwin Ram and Jay Shepard. Neal Fowler is the CEO of Pathalys.

Here are the details of Pathalys' key team members:

Takeshi Takahashi: Co-Founder of Pathalys.
Contact Info: 1 email address
Mahesh Krishnan: Co-Founder of Pathalys.
Contact Info: 1 email address
BT Slingsby: Co-Founder of Pathalys.
Contact Info: 1 email address
Ashwin Ram: Co-Founder of Pathalys.
Contact Info: 1 email address
Jay Shepard: Co-Founder of Pathalys.
Contact Info: 1 email address

View details of Pathalys's Founder profiles and Board Members

Pathalys' employee count trend

Pathalys has 18 employees as of Sep 26. Here is Pathalys's employee count trend over the years:

Uncover Pathalys' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Pathalys include Aqtual, Evergreen Nephrology and AdaptX. Here is the list of Top 10 competitors of Pathalys, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Aqtual 2017, San Francisco (United States), Series B	Provider of clinical product launching, chronic disease solution, and diagnostic platform services	$47M	Genoa Ventures, Manta Ray Ventures & 3 others	48/100
2nd	Evergreen Nephrology 2021, Nashville (United States), Series D	Provider of chronic care management services for kidney diseases	$130M	Oak HC/FT, Rubicon Founders & 3 others	43/100
3rd	AdaptX 2016, Seattle (United States), Series A	Provider of clinical management solutions	$23.7M	Cercano Management, Arnold Venture Group & 8 others	42/100
4th	Ceresti 2013, Carlsbad (United States), Series B	Provider of chronic care management and monitoring solutions	$36.1M	Prairie Ventures, UCSF Rosenman Institute ... & 4 others	41/100
5th	Vivecti Group 2023, Ulm (Germany), Funding Raised	Healthcare performance partner offering patient care management services	-	Nordic Capital	41/100
6th	Future Cardia 2021, Houston (United States), Series A	Provider of chronic care management services	$5M	La Jolla Holding, Empire Group International	40/100
7th	HealthNEXT 2008, Philadelphia (United States), Acquired	Provider of patient management solutions	$200K	Archetype	39/100
8th	AMA 2023, St. Louis (United States), Unfunded	Provider of patient monitoring services	-	-	38/100
9th	Phyathai Hospital 1976, Bangkok (Thailand), Unfunded	Provider of medical care services	-	-	38/100
10th	Tria Health 2009, Overland Park (United States), Unfunded	Provider of chronic care management services	-	-	37/100
12th	Pathalys 2021, Raleigh (United States), Series B	Provider of CKD biotherapeutics development services	$105M	Marshall Wace, Abingworth & 9 others	36/100